Tenderwize
Retour à la recherche

Accord de rabais non exclusif pour naproxène et ésoméprazole

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Jun 27, 2027 · 218 days left·Open·Supplies·Framework
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Naproxen und Esomeprazol (ATC-Code: M01AE52).

47/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

47 / 100

Complexité

58 / 100

Facteurs de risque

The notice text specifies 28 July 2025 for participation from 1 September 2025, while the structured data and XML speci...

No contract value, expected volume, minimum commitment, or guaranteed demand is provided.

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Niedersachsen. Die Gesundheitskasse.
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Jun 27, 2027

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Supply of medicines containing the active-ingredient combination naproxen and esomeprazole, ATC code M01AE52.
  • Conclusion of non-exclusive rebate agreements with AOK Niedersachsen under § 130a(8) SGB V.
Afficher le résumé complet

Open-house, non-exclusive pharmaceutical rebate agreement offered by AOK Niedersachsen for medicines combining naproxen and esomeprazole (ATC M01AE52) in Germany. Eligible pharmaceutical undertakings may join without a selection decision under uniform, non-negotiable conditions. The agreement may be concluded during the term, but contracts can end early if exclusive rebate contracts enter into force. Contract documents were not provided for analysis, the value is not stated, and the initial joining deadline of 28 July 2025 conflicts with the structured/XML deadline of 27 June 2027.

Risques

The notice text specifies 28 July 2025 for participation from 1 September 2025, while the structured data and XML speci...

No contract value, expected volume, minimum commitment, or guaranteed demand is provided.

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • The participant must be a pharmaceutical undertaking within the meaning of § 4(18) AMG, or a contractual association of pharmaceutical undertakings, in relation to the offered...
  • The pharmaceutical undertaking must have its seat in Germany, another EU Member State, or another EEA contracting state for medicines placed on the German market.
  • A local representative may participate only if it is itself a pharmaceutical undertaking within the meaning of § 4(18) AMG for the medicines concerned.

Critères d'attribution

Lot 1

Price is identified as the award criterion, but no description or weighting is provided. The open-house model indicates that no competitive selection decision is intended.

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Naproxen and Esomeprazole Pharmaceutical Rebate Agreement

Non-exclusive open-house rebate agreement under § 130a(8) SGB V for medicines containing naproxen and esomeprazole (ATC M01AE52). AOK Niedersachsen intends to offer identical contract terms to all interested eligible pharmaceutical undertakings without a selection decision or individual negotiations. Contracts may start on the first day of a month, run for a maximum of 24 months, and end no later than 31 August 2027.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

Aug 2025 - Aug 2027

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Deadline Jun 27, 2027

Détails de la procédure

Date de publication
08 Jul 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
446910-2025

Appels d'offres similaires

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy